Skip to main content
Cancers logoLink to Cancers
. 2020 Oct 14;12(10):2971. doi: 10.3390/cancers12102971

Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). Cancers 2020, 12, 176

Sarah N Mapelli 1,2, Domenico Albino 1, Maurizia Mello-Grand 3, Dheeraj Shinde 1, Manuel Scimeca 4, Rita Bonfiglio 4, Elena Bonanno 4, Giovanna Chiorino 3, Ramon Garcia-Escudero 5,6,7,*, Carlo V Catapano 1,2,8,*, Giuseppina M Carbone 1,*
PMCID: PMC7602137  PMID: 33066424

There is an error in the title of the paper [1]. The authors thus wish to make the following correction to this paper [1]:

Change the title from “A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)” to “A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response”.

We apologize for this error and state that the scientific conclusions are unaffected. The original article has been updated.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Mapelli S.N., Albino D., Mello-Grand M., Shinde D., Scimeca M., Bonfiglio R., Bonanno E., Chiorino G., Garcia-Escudero R., Catapano C.V., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors) Cancers. 2020;12:176. doi: 10.3390/cancers12010176. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES